Moreover, using hepatocyte-specific EYA2-knockout mice (Eya2−/−), we demonstrated that EYA2 acted as a tumor suppressor in the occurrence and progression of HCC through SOCS3-mediated blockade of JAK/STAT signaling. The gene discussed is SOAT1; the disease is hepatocellular carcinoma.